Yue Wu
About Yue Wu
Yue Wu is a Senior Principle Investigator at Beigene in Cambridge, Massachusetts, with extensive experience in pharmacology and drug research.
Title at Beigene
Yue Wu holds the position of Senior Principal Investigator at Beigene, located in Cambridge, Massachusetts, United States. In this role, Yue Wu is likely involved in conducting advanced research and investigations pivotal to the company’s drug discovery and development initiatives.
Work Experience at Novo Nordisk
Yue Wu spent a significant part of their career at Novo Nordisk in Denmark. From 2011 to 2018, they progressed through several key positions: starting as a Research Information Scientist, then becoming a Senior Research Information Scientist, and later a Senior Scientist. This tenure allowed Yue Wu to develop extensive expertise in areas such as pharmacokinetics and new drug target screening.
Education and Degrees
Yue Wu has a robust educational background in pharmacology and pharmacy. They earned a Doctor of Philosophy in Pharmacology from the University of Adelaide, a Master of Science in Pharmacy from Peking University, and a Bachelor of Science in Pharmacy from Peking University. Additionally, Yue Wu studied at Renmin University of China, further enriching their academic foundation.
Expertise in PBPK Modeling and Human PK Prediction
Yue Wu is highly skilled in Physiologically-Based Pharmacokinetic (PBPK) modeling, which plays a crucial role in predicting drug behavior in the human body. Their specialization in human pharmacokinetics (PK) prediction is essential for the clinical development of new drugs, ensuring accurate dosing and effective therapeutic outcomes.
Skills in PKPD Study Design and Metabolic Disease Research
Yue Wu possesses significant expertise in designing Pharmacokinetic-Pharmacodynamic (PKPD) studies, critical for understanding the correlation between drug concentration and its effects. They also have substantial experience using animal models to research metabolic diseases such as diabetes, obesity, and atherosclerosis, contributing vital knowledge to these fields.
Proficiency in Drug Discovery Processes
Yue Wu is proficient in screening and evaluating new drug targets, a fundamental aspect of the drug discovery process. Additionally, they conduct scientific and patent information searches and analyses, including freedom to operate analysis. These activities are essential for ensuring new pharmaceuticals do not infringe on existing patents, facilitating smooth progress in drug development.